- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.01. | Clinical Laserthermia Systems AB: TRANBERG Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands | 1 | Cision News | ||
| 12.12.25 | Clinical Laserthermia Systems AB: CLS initiates recruitment process for permanent Chief Financial Officer | 122 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS") today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a permanent and fully employed... ► Artikel lesen | |
| 03.12.25 | Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prismbranded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery | 1 | Cision News | ||
| CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 14.11.25 | Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - September 2025 | 860 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - September 2025.Highlights of the Third Quarter Interim ReportDuring the... ► Artikel lesen | |
| 07.10.25 | Clinical Laserthermia Systems AB: CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | 122 | GlobeNewswire (Europe) | Lund, Sweden, October 7th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS") today announces positive results from a clinical safety study on laser ablation, performed using CLS proprietary LITT... ► Artikel lesen | |
| 30.09.25 | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B | 1 | Cision News | ||
| 04.09.25 | Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 1 | Cision News | ||
| 04.09.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 259 | GlobeNewswire (Europe) | Lund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for expansion... ► Artikel lesen | |
| 22.08.25 | Clinical Laserthermia Systems AB: CLS publishes half-year report January - June 2025 | 258 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report January - June 2025. Second Quarter Highlights
Record sales revenue of SEK 9,4M... ► Artikel lesen | |
| 16.05.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Interim report for January - March 2025 | 234 | GlobeNewswire (Europe) | Summary of the interim report (relates to the Group)Three months (01/01/2025-03/31/2025)
Net sales totaled SEK 4,496,000 (SEK 3,140,000).
Operating profit totaled SEK -7,868,000 (SEK -16,992,000).
Profit/loss... ► Artikel lesen | |
| 28.04.25 | ClearPoint Neuro, Inc.: ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism to Include 1.5 T MRI | 223 | ACCESS Newswire | SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the... ► Artikel lesen | |
| 15.04.25 | Clinical Laserthermia Systems AB: Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis | 246 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS or the "Company") today announces that updated clinical guidelines with recommendations supporting the use of Laser Interstitial Thermal Therapy (LITT)... ► Artikel lesen | |
| 08.04.25 | Clinical Laserthermia Systems AB: Proposed U.S. tariffs expected to have minimal impact on CLS business | 197 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") clarifies that the proposed U.S. tariffs are expected to have minimal impact on its total business, including operations... ► Artikel lesen | |
| 21.02.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024 | 349 | GlobeNewswire (Europe) | Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024)
Net sales totaled SEK 18,783,000 (SEK 8,273,000).
Operating profit/loss totaled SEK -54,254,000 (SEK -65,933... ► Artikel lesen | |
| 07.02.25 | Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | 1.282 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,470 | +1,74 % | Fresenius: Nach 5-Jahres-Hoch - Analysten weiter optimistisch | Der Trading-Tipp des Tages ist diesmal Fresenius. In diesem Jahr läuft es für die Aktie bisher sehr gut. Gestern erreichte das Papier sogar ein 5-Jahres-Hoch. Heute findet sich Fresenius zwar am DAX-Ende... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 29,340 | -16,65 % | Goldman Sachs senkt Daumen: Deutsche Medizintechniker Carl Zeiss Meditec und Fresenius Medical Care sacken ab | Goldman Sachs streicht die Kaufempfehlung für zwei Medizintechnik-Spezialisten und schlägt damit Anleger in die Flucht: um fünf Prozent rauscht der MDAX-Wert Carl Zeiss Meditec in der Früh in die Tiefe... ► Artikel lesen | |
| DRAEGERWERK | 85,90 | -0,58 % | DAX-Check LIVE: Drägerwerk Vz., Fraport, Jenoptik, Klöckner & Co., SAF-Holland, Verbio im Fokus | Nach den Verlusten vom Mittwoch hat der DAX am Donnerstag wieder zugelegt - bei insgesamt zurückhaltendem Handel. Über weite Strecken bewegte sich der Leitindex kaum, erst in den letzten Minuten kam... ► Artikel lesen | |
| MEDTRONIC | 86,34 | +0,63 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| INTUITIVE SURGICAL | 446,50 | -0,33 % | Polen Focus Growth Fund adds ISRG; exits NFLX and WDAY | ||
| THERMO FISHER | 543,50 | -0,18 % | Schlägt Thermo Fisher zu?: Qiagen: Übernahmegerüchte schicken die Aktie auf Kursachterbahn | © Foto: Rafael Henrique - picture allianceÜbernahmegerüchte um den Diagnostikspezialisten Qiagen sorgten am Dienstag für einen rekordverdächtigen Kursanstieg. Am Mittwoch kommt die Aktie wieder etwas... ► Artikel lesen | |
| TELADOC HEALTH | 5,403 | +2,58 % | SA analyst upgrades/downgrades: T, AMZN, Z, TDOC | ||
| ROKU | 91,10 | +2,14 % | How I turned my cheap Roku TV into a piece of art (like the $3,000 Samsung Frame TV) | ||
| HIMS & HERS HEALTH | 26,040 | +5,34 % | HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling? | ||
| SERNOVA BIOTHERAPEUTICS | 0,096 | -2,05 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| DEXCOM | 62,60 | +1,44 % | DexCom Stock Declines Following Strong Preliminary Q4 Results | ||
| ALCON | 69,54 | -0,20 % | Alcon Completes $750 Million Share Repurchase Program | Alcon Inc., the global leader in eye care dedicated to helping people see brilliantly, today announced the completion of its $750 million share repurchase program, which commenced on April 1, 2025.... ► Artikel lesen | |
| RESMED | 221,30 | -0,27 % | Resmed promotes new chief strategy officer from within | ||
| HEALWELL AI | 0,543 | +3,14 % | HEALWELL AI: HEALWELL AI Provides Additional Information Regarding November 3, 2025, Release Where it Announced Strategic Divestments | Toronto, Ontario--(Newsfile Corp. - December 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,110 | +1,10 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Der Konzernchef sowie der Finanzvorstand hätten... ► Artikel lesen |
Das Unternehmen CLINICAL LASERTHERMIA SYSTEMS AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,31 % bei einem Aktienkurs von 0,639 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLINICAL LASERTHERMIA SYSTEMS AB finden Sie auf Wallstreet Online.